On February 16, 2026, at 2:30 PM JST, our Founder and Chief Innovation Officer (CIO), Ogawa, will speak at a seminar hosted by the Drug Discovery Modality Study Group of the Japan Bioindustry Association (JBA).

At the seminar, he will present MOLCURE’s AI-driven strategy for next-generation antibody discovery, highlighting the recent research trends as well as our approach to the real-world deployment of our AI technology.

The seminar will be held in a hybrid format, and participation is free of charge. Eligible participants include JBA corporate members and individual JBA members from academia. For further details, please visit the official event page (link).